The Oncology Institute Announces Second Quarter 2026 Earnings Release Date and Conference Call
Go back to The Oncology Institute Announces Second Quarter 2026 Earnings Release Date and Conference Call| TARGETS Trust XXIV 7% TARGETS with respect to the common stock of Intel Corporation (NASDAQ: TOI) | Delayed: 5.13 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.13 | 52 Week High | $7.47 | |||
| Open | $5.13 | 52 Week Low | $7.47 | |||
| Day High | $5.13 | P/E | N/A | |||
| Day Low | $5.13 | EPS | $0.00 | |||
| Volume | 15,000 | |||||
| TARGETS Trust XXIV 7% TARGETS with respect to the common stock of Intel Corporation (NASDAQ: TOI) | Delayed: 5.13 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.13 | 52 Week High | $7.47 | |||
| Open | $5.13 | 52 Week Low | $7.47 | |||
| Day High | $5.13 | P/E | N/A | |||
| Day Low | $5.13 | EPS | $0.00 | |||
| Volume | 15,000 | |||||
